相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients
Allison L. M. Jordan et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Elise A. Olsen et al.
BLOOD (2022)
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma
Sara Beygi et al.
BLOOD (2022)
ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
Reshma Raghava Kurup et al.
SCIENTIFIC REPORTS (2022)
The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma
Julia J. Scarisbrick et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature
Cinzia Dello Russo et al.
PHARMACOLOGY & THERAPEUTICS (2021)
The importance of assessing blood tumour burden in cutaneous T-cell lymphoma
M. H. Vermeer et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
Darci Phillips et al.
NATURE COMMUNICATIONS (2021)
Quality of life in patients with Mycosis Fungoides and Sezary Syndrome: a systematic review of the literature
R. Ottevanger et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
CODEX multiplexed tissue imaging with DNA-conjugated antibodies
Sarah Black et al.
NATURE PROTOCOLS (2021)
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sezary Syndrome: A Multicenter Phase II Study
Michael S. Khodadoust et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer
Atena Soleimani et al.
GENE (2020)
Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis
Florentia Dimitriou et al.
FRONTIERS IN MEDICINE (2020)
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
Auris Huen et al.
CANCERS (2020)
Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas
Maelle Dumont et al.
CANCERS (2020)
Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma
Wen-Kai Weng et al.
BLOOD ADVANCES (2020)
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Stephanie Kourakis et al.
PHARMACEUTICALS (2020)
Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front (vol 182, pg 1341, 2020)
Christian M. Schurch et al.
CELL (2020)
Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma
Tabea C. Froehlich et al.
BLOOD (2019)
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
Martine Bagot et al.
LANCET ONCOLOGY (2019)
Dimethyl Fumarate: A Review in Relapsing-Remitting MS
Hannah A. Blair
DRUGS (2019)
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
Rein Willemze et al.
BLOOD (2019)
Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus
U. Mrowietz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Youn H. Kim et al.
LANCET ONCOLOGY (2018)
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome - Update 2017
Franz Trautinger et al.
EUROPEAN JOURNAL OF CANCER (2017)
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
H. Miles Prince et al.
LANCET (2017)
Targeting Thioredoxin-1 by dimethyl fumarate induces ripoptosome-mediated cell death
Anne Schroeder et al.
SCIENTIFIC REPORTS (2017)
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting F-κB
Jan P. Nicolay et al.
BLOOD (2016)
Cutaneous T-cell lymphomas: an urgent need for more improved therapies
J. J. Scari
BRITISH JOURNAL OF DERMATOLOGY (2016)
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
Madeleine Duvic et al.
BLOOD (2015)
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
Julia J. Scarisbrick et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2
Alexander Ungewickell et al.
NATURE GENETICS (2015)
Lack of durable disease control with chemotherapy for mycosis fungoides and Sezary syndrome: a comparative study of systemic therapy
Charlotte F. M. Hughes et al.
BLOOD (2015)
Long-Term Outcome of Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sezary Syndrome: A European Society for Blood and Marrow Transplantation Lymphoma Working Party Extended Analysis
Rafael F. Duarte et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo
Gloria Lutzny et al.
CANCER CELL (2013)
A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes
Markus Brechmann et al.
IMMUNITY (2012)
Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Elise A. Olsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sezary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
Nita Sally Agar et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Inhibition of Constitutively Activated Nuclear Factor-κB Induces Reactive Oxygen Species- and Iron-Dependent Cell Death in Cutaneous T-Cell Lymphoma
Michael K. Kiessling et al.
CANCER RESEARCH (2009)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise Olsen et al.
BLOOD (2007)
Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
A Sors et al.
BLOOD (2006)
HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death
K Gülow et al.
JOURNAL OF IMMUNOLOGY (2005)